The KCNK3 Knockout NCI-H1299 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the human KCNK3 gene has been disrupted to abolish expression of the TASK-1 two-pore domain potassium channel. This polyclonal knockout model, derived from the NCI-H1299 lung carcinoma epithelial cell line, provides a heterogeneous loss-of-function system suitable for interrogating KCNK3-dependent signaling without clonal selection artifacts. The engineered disruption enables functional studies of TASK-1-mediated background potassium currents and their contributions to membrane potential regulation in a non-small cell lung cancer context.
The host NCI-H1299 cell line, established from a lymph node metastasis of a non-small cell lung carcinoma, is widely utilized in cancer biology and preclinical drug response investigations. Notably, NCI-H1299 cells lack functional p53 tumor suppressor expression, rendering them a valuable platform for examining apoptosis, DNA damage responses, and chemoresistance pathways independent of p53-mediated mechanisms. Their epithelial origin and rapid proliferation make them well-suited for ion channel research, particularly in exploring how potassium channel activity intersects with malignant phenotypes such as migration, invasion, and drug sensitivity in advanced lung cancer models.
KCNK3 encodes TASK-1, a pH- and hypoxia-sensitive background potassium channel that stabilizes resting membrane potential. Channel activity is modulated by upstream regulators including hypoxia, serotonin receptors, angiotensin II receptors, protein kinase A, protein kinase C, and extracellular pH changes. Upon KCNK3 disruption, membrane depolarization occurs, leading to activation of voltage-gated calcium channels and subsequent calcium influx. This triggers downstream calcium-dependent signaling cascades involving calcineurin and NFAT, while also impacting cell proliferation modulation. KCNK3 interacts with 14-3-3 proteins (YWHAE and YWHAB), the related potassium channel KCNK1 (TWIK-1), and the small GTPase ARF1, further linking TASK-1 to vesicular trafficking and signaling scaffold functions. The pathway encompasses HIF-1??-mediated hypoxic responses, phospholipase C?Cdiacylglycerol?Cprotein kinase C axis, and voltage-gated calcium channel?Ccalcineurin?CNFAT transcriptional programs, providing multiple nodes for mechanistic dissection.
In the NCI-H1299 background, KCNK3 knockout is hypothesized to alter cellular responses to hypoxia and pharmacological challenges relevant to lung cancer progression. Loss of TASK-1-dependent potassium conductance may enhance membrane excitability and calcium signaling, potentially affecting proliferation, apoptosis resistance, and migratory capacity. Given the p53-null status, this model permits evaluation of KCNK3-mediated pathways in apoptosis regulation and drug sensitivity without confounding p53-dependent effects, making it particularly relevant for studying chemoresistance mechanisms and identifying novel therapeutic vulnerabilities in non-small cell lung cancer.
Researchers can employ these polyclonal knockout cells in a variety of advanced assays, including patch-clamp electrophysiology to directly measure potassium current ablation, membrane potential-sensitive fluorescent dye experiments, and calcium imaging to quantify alterations in intracellular calcium dynamics. Functional studies may encompass MTT proliferation assays, annexin V apoptosis detection, transwell migration assessments, and cisplatin sensitivity profiling under normoxic and hypoxic conditions. Additionally, western blotting for phosphorylated signaling intermediates and RT-qPCR for downstream target gene expression enable molecular pathway verification. For detailed product information, technical support, or to discuss custom applications, please contact Ascent Research.
